Skip to main content
Day.News — Local News. Real Community.
SCOTT COUNTY DAY NEWS
Local News. Real Community.

Health & Wellness

08/18/2026 · Scott County

Full Edition
FDA Approves Subcutaneous Leqembi Starting Dose for Alzheimer's Treatment

FDA Approves Subcutaneous Leqembi Starting Dose for Alzheimer's Treatment

The FDA has approved a weekly subcutaneous starting dose for Leqembi, a drug for early Alzheimer's. This approval provides an alternative administration method for patients. The Alzheimer's Drug Discovery Foundation commented on the development.

08/19/2026
Read Story
Health

Home Oxygen Access Challenges Delay Hospital Discharges Nationwide

A recent national survey indicates that restricted access to high-flow home oxygen equipment prolongs patient stays in hospitals. These delays reportedly increase both financial burdens and health risks for individuals. The issue also impacts healthcare system costs.

07/29/2026 · Tennessee

Health

FDA Approves Oral PCSK9 Inhibitor for Cholesterol Reduction

The U.S. Food and Drug Administration has approved Lipfendra (enlicitide), an oral medication designed to lower LDL cholesterol. This approval marks the first time an oral PCSK9 inhibitor has received authorization for use in adults with high cholesterol.

07/27/2026 · Tennessee

Health

Healthcare-Associated Infections Declined in 2023, CDC Reports

New data from the Centers for Disease Control and Prevention indicates a decline in healthcare-associated infections during 2023. These findings highlight changes within patient safety initiatives.

07/26/2026 · Tennessee

Health

FDA Proposes Rule to Enhance Oversight of Foreign Tobacco Products

The U.S. Food and Drug Administration has proposed a new rule to strengthen its ability to identify and block illegally imported foreign tobacco products. This measure seeks to protect public health by preventing unauthorized tobacco from entering the U.S. market.

07/21/2026 · Tennessee

Health

FDA Approves First Gene Therapy for Young Children with Sickle Cell Disease

The U.S. Food and Drug Administration has granted supplemental approval for Casgevy, a gene therapy. This approval targets children aged two years and older with sickle cell disease or transfusion-dependent beta thalassemia.

07/21/2026 · Tennessee

More Health & Wellness

Sponsored

Advertisement

Advertisement

Advertisement